Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SHW vs GSK✓SelectedUSD · GSKSHW vs GSK performance historyLatest closeAs of-1.95%11/19
Stock and ETF performance explorer

SHW vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+7.1%
GSK return
+39.6%
Excess return
-32.5%
Maximum drawdown
-42.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.0%-1.6%-0.4%-1.5%
7D-3.1%-4.7%+1.6%-1.8%
30D+1.4%-4.7%+6.1%+2.7%
3M-3.4%-8.8%+5.3%-1.1%
6M+14.5%-4.6%+19.1%+15.9%
YTD+5.9%+1.0%+4.9%+5.9%
1Y+4.0%+6.9%-2.9%+2.8%
3Y+29.1%+52.5%-23.4%+16.2%
5Y+7.1%+40.3%-33.2%-10.5%
All+7.1%+39.6%-32.5%-10.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling